Feeds:
Posts
Comments

Archive for the ‘NICE’ Category

Click on the picture to enlarge …
By: Jeremy Laurance, Health Editor, The Independent
Friday, 8 August 2008
“Why are we asking this now?
Cancer charities, kidney specialists and campaigners were outraged yesterday when the National Institute for Clinical Excellence (Nice), announced that it had rejected four new drugs for advanced kidney cancer as too [...]

Read Full Post »

News: Andrew Cole – BMJ, 11 January 2008
The House of Commons health select committee has called for a major shake-up in the way the National Institute for Health and Clinical Excellence (NICE) assesses new treatments.

Read Full Post »

Many GP’s and other healthcare professionals don’t know much about ME. (Myalgic Encephalomyelitis [WHO ICD-10:G93.3])
They think it is the same as tiredness and that impression is further reinforced by the recent NICE guidelines that proclaim that tiredness and a sore throat or headache equals ME. Nothing is further from the truth. Here is a quick guideline for [...]

Read Full Post »

BMJ 2007;335:275 (11 August).
Anaesthetists get new guidelines for morbidly obese patients
BY: Toby Reynolds
The rising number of morbidly obese people in the UK population has prompted anaesthetists to write new guidelines for managing these higher risk patients, emphasising the need for training and suitable equipment.
In England nearly 3% of women and 1% of men are [...]

Read Full Post »

Janice Hopkins Tanne; BMJ  2007;335:226 (4 August).

Patients with severe Alzheimer’s disease who are living at home with family care givers and are treated with donepezil stabilise or decline more slowly than patients given placebo, according to a multinational, randomised, placebo controlled trial published in Neurology (2007;69:459-69).
North American researchers were suspicious of the decision by the UK [...]

Read Full Post »

New guidance from the National Institute for Health and Clinical Excellence recommends Herceptin in early breast cancer, but it provides no additional funding or any suggestion of which services to cut. This leaves medical staff with difficult decisions to make.
The media have made little mention of the restricted categories of patients for whom Herceptin may [...]

Read Full Post »